![Leon Hooftman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Leon Hooftman
Hoofd Techniek/Wetenschap/O&O bij
BARINTHUS BIOTHERAPEUTICS PLC
Vermogen: - $ op 31-07-2026
Profiel
Leon Hooftman currently works at Barinthus Biotherapeutics Plc, as Chief Medical Officer from 2024.
Dr. Hooftman also formerly worked at Hoffmann-La Roche, Inc., as Director-Clinical Science, Celltech Group Plc, as Head-Clinical Development, Chroma Therapeutics Ltd., as Chief Medical Officer, Syntex, Inc., as Senior Clinical Research Physician, Opsona Therapeutics Ltd., as Chief Medical Officer, and DCPrime BV, as Member-Supervisory Board.
Dr. Hooftman received his undergraduate degree from the University of Utrecht and doctorate degree in 1984 from the University of Utrecht.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 05-06-2026 | 0 ( -.--% ) | - $ | 31-07-2026 |
Actieve functies van Leon Hooftman
| Bedrijven | Functie | Begin |
|---|---|---|
| BARINTHUS BIOTHERAPEUTICS PLC | Hoofd Techniek/Wetenschap/O&O | 01-06-2024 |
Eerdere bekende functies van Leon Hooftman
| Bedrijven | Functie | Einde |
|---|---|---|
DCPrime BV
 DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Directeur/Bestuurslid | - |
Syntex, Inc.
 Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Corporate Officer/Principal | - |
Opsona Therapeutics Ltd.
 Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Hoofd Techniek/Wetenschap/O&O | - |
Celltech Group Plc
 Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Leon Hooftman
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
37
Eerstegraads connecties
8
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 8 |
|---|---|
Celltech Group Plc
Celltech Group Plc BiotechnologyHealth Technology Develops and manufactures pharmaceuticals | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
Chroma Therapeutics Ltd.
 Chroma Therapeutics Ltd. BiotechnologyHealth Technology Engages in the discovery and development of therapies for the treatment of cancer and inflammation | Health Technology |
University of Utrecht
 University of Utrecht Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syntex, Inc.
Syntex, Inc. MiscellaneousMiscellaneous Operates as a non-classified establishment | Miscellaneous |
Opsona Therapeutics Ltd.
Opsona Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides immunology drug for treatment of inflammatory diseases | Health Technology |
DCPrime BV
DCPrime BV Pharmaceuticals: MajorHealth Technology Provides therapeutic vaccines for the treatment of cancer | Health Technology |
Vaccitech Plc
 Vaccitech Plc Pharmaceuticals: MajorHealth Technology Discovers and develops immunotherapeutic products and vaccines for the treatment and prevention of infectious and cancer diseases | Health Technology |
